Wednesday, December 20, 2017 1:02:12 AM
Toronto, Ontario--(Newsfile Corp. - December 19, 2017) - VITALHUB CORP. (TSXV: VHI) (the "Company" or "Vitalhub"), is pleased to announce that it has completed the previously announced non-brokered private placement (the "Offering") of units (the "Units") at a price of $0.115 per Unit, for total gross proceeds of $2,000,000. Each Unit consisted of one common share (each, a "Common Share") and one half of one Common Share purchase warrant (each a "Warrant"). Each Warrant is exercisable into one Common Share at an exercise price of $0.18 per Common Share, for a period of two (2) years from the date of issuance.
Pursuant to the Offering, the Company issued a total of 17,389,352 Common Shares and 8,694,676 Warrants. In connection with the Offering, the Company paid finder's fees totaling $120,185.77 and issued a total of 1,045,055 finder's warrants (each a "Finder Warrant") to certain persons responsible for facilitating subscribers to the Offering. The Finder's Warrants are non-transferable common share purchase warrants which entitle the holder to exercise into one Common Share at an exercise price of $0.18 per Common Share, for a period of two (2) years from the date of issuance.
The Company intends to use the net proceeds of the Offering for general working capital purposes.
All securities issued in connection with the Offering are subject to a four month hold period expiring April 20, 2018.
About VitalHub
VitalHub delivers an innovate platform for the creation of mobile health applications that increases productivity within healthcare settings. The VitalHub platform provides the ability to integrate existing individual healthcare applications while maintaining the control, security and privacy essential in healthcare. VitalHub's applications are focused on the fast-growing mental health and long term care markets and the company plans to strategically acquire and grow business in these areas. Currently over 50 healthcare institutions across Canada use products from VitalHub and its subsidiaries.
Recent VHI News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:16:59 PM
- VALHI REPORTS FOURTH QUARTER 2023 RESULTS • GlobeNewswire Inc. • 03/07/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:17:01 PM
- VALHI DECLARES QUARTERLY DIVIDEND • GlobeNewswire Inc. • 02/29/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 09:39:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 09:16:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 09:15:51 PM
- VALHI REPORTS THIRD QUARTER 2023 RESULTS • GlobeNewswire Inc. • 11/06/2023 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:19:31 PM
- VALHI DECLARES QUARTERLY DIVIDEND • GlobeNewswire Inc. • 11/02/2023 08:15:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/02/2023 08:00:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 08:19:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:18:48 PM
- VALHI DECLARES QUARTERLY DIVIDEND • GlobeNewswire Inc. • 08/03/2023 08:17:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/03/2023 08:15:50 PM
- VALHI REPORTS SECOND QUARTER 2023 RESULTS • GlobeNewswire Inc. • 08/03/2023 08:15:00 PM
- UPDATE--VALHI ANNOUNCES QUARTERLY CASH DIVIDEND AND RESULTS OF ANNUAL STOCKHOLDER MEETING • GlobeNewswire Inc. • 05/25/2023 09:09:58 PM
- VALHI ANNOUNCES QUARTERLY CASH DIVIDEND AND RESULTS OF ANNUAL STOCKHOLDER MEETING • GlobeNewswire Inc. • 05/25/2023 08:15:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM